COVID-19 trials registries data warehouse

https://clinicaltrials.gov/show/NCT04581291

Motaz Alawna

Not reported

2020-10-09

Completed

RCT

Randomized

Parallel

Blind label

single-center

Treatment

inclusion criteria: - the patient has a recent mild or moderate covid-19 with no or low-grade fever 99.5- 100.94 °f (37.5-38.3 °c). mild covid-19 included that the patient has symptoms of acute upper respiratory tract infection (fever, cough, myalgia, runny nose, fatigue, sore throat, sneezing) or gastrointestinal symptoms (nausea, vomiting, abdominal pain, diarrhea). moderate grade of covid 19 included that the participant has pneumonia (cough, frequent fever) with no obvious hypoxemia, the presence of lesions on chest ct

- that patient was not hospitalized and has moderate or high-grade fever <100.94 °f (<38.3 °c) or other chronic diseases such as heart problems, hypertension or diabetes. women how were using contraceptives were excluded due to contraceptives decrease immune functions and might affect the subjectivity to autoimmune disorders with marked increases in risk for various autoimmune disorders

2

Istanbul Gelisim University

24

45

Turkey

Mild/moderate disease at enrollment

2: Mild/moderate disease at enrollment

30

Upper respiratory tract infection symptoms severity and progression;Immune system markers

None

Not reported

[{"arm_notes": "", "treatment_id": 987, "treatment_name": "Physical exercises", "treatment_type": "Rehabilitation", "pharmacological_treatment": "Non pharmacological treatment"}, {"arm_notes": "", "treatment_id": 2188, "treatment_name": "Standard of care", "treatment_type": "Standard of care", "pharmacological_treatment": "Standard of care"}]